Primary hypogonadism (congenital or acquired): Testicular failure due to diseases and conditions in the body such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter Syndrome, chemotherapy, or toxic damage from alcohol or heavy metals; these men usually have low serum testosterone levels and gonadotropins (FSH, LH) above normal range Hypogonadotropic hypogonadism (congenital or acquired): Gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation; these men have low testosterone serum concentrations but have gonadotropins in the normal or low range.
A Testosterone Propionate cycle during a cutting phase is an excellent way to ensure muscle mass isn’t lost during a diet. You will also find it enhances fat loss efficiency and produces a stronger more defined look. As with the off-season Testosterone Propionate cycle, the total stack and doses may need to be adjusted in order to meet your needs; again, this is a sample guide. It is also important you consult with your doctor to ensure you’re healthy enough for use. Important Note – This type of Testosterone Propionate cycle will not produce less or more water retention compared to plans that might contain Testosterone Cypionate or Testosterone Enanthate in the Propionate versions place. It’s often assumed by many steroid users that Testosterone Propionate will yield less water retention than the aforementioned versions but that’s a myth. Testosterone is testosterone and does not become active in the body until the ester has been removed. The reason many believe it leads to less water retention is a very simple one; most given extra attention to their diet and estrogen control during a cutting phase, and this will always lead to less water retention in a Testosterone Propionate cycle or any cycle.
Fluid and electrolyte disturbances: Retention of sodium, chloride, water, potassium, calcium, and inorganic phosphates.
Gastrointestinal: Nausea, cholestatic jaundice, alterations in liver function tests, rarely hepatocellular neoplasms and peliosis hepatis (see WARNINGS ).
Hematologic: Suppression of clotting factors II, V, VII, and X, bleeding in patients on concomitant anticoagulant therapy, and polycythemia.
Nervous system: Increased or decreased libido, headache, anxiety, depression, and generalized paresthesia.
Allergic: Hypersensitivity, including skin manifestations and anaphylactoid reactions.
Vascular Disorders: venous thromboembolism
Miscellaneous: Inflammation and pain at the site of intramuscular injection.